Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab
Dr. Jean-Pierre Llanos Ackert and Dr. Chris Ambrose discuss the latest data on the breakthrough biologic for severe asthma.
Source: hcplive.com
Stay updated with breaking news from Ambrose Stated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Jean-Pierre Llanos Ackert and Dr. Chris Ambrose discuss the latest data on the breakthrough biologic for severe asthma.
Investigators Dr. Jean-Pierre Llanos Ackert and Dr. Chris Ambrose share insight on the efficacy of tezepelumab in severe, uncontrolled asthma, and baseline predictors of enhanced response which support tezepelumab as a promising biologic treatment option.